How is early non-small cell lung cancer treated with surgery or SBRT?

Usually, cancers that are limited to a small area of the chest are best treated with a local treatment to remove or kill the entire tumor. Surgery and stereotactic body radiation therapy (SBRT) also known as stereotactic ablative radiotherapy (SABR) are forms of local treatment. Surgery to remove the cancer may be the best option for early NSCLC, if the tumor is small. Surgery is generally more effective than SBRT in removing all the cancer, but not everyone can safely tolerate surgery, or some individuals may opt for a non-surgical approach.

Surgery

Different operations can be used to treat (and possibly cure) NSCLC. With any of these operations, nearby lymph nodes are also removed to look for possible spread of the cancer. Surgery will require general anesthesia (where you are in a deep sleep) and are usually done through a large surgical incision between the ribs in the side of the chest or the back (called a thoracotomy). The 4 most commonly used surgeries for early NSCLC are listed in the table below.

The type of surgery you get depends on the size and location of the tumor and on how well your lungs work. If your lungs are healthy, your doctor may do a larger surgery to give the best chance for cure.

When you wake up from surgery, you will have a tube (or tubes) coming out of your chest and attached to a special container to allow excess fluid and air to drain out. The tube(s) will be removed once the fluid drainage and air leak slow down. Generally, you will need to spend 5 to 7 days in the hospital after the surgery.

Non-Surgery Treatments

Other treatment options include radiation and systemic therapy.

Systemic Therapy

Systemic therapy is used alone or in combination with other therapies (for example surgery or radiation) to control your cancer. Types of systemic therapy used in early NSCLC include:

  • Chemotherapy – drugs that kill fast growing cells, including cancer cells
  • Immunotherapy – drugs that use your own immune system to kill cancer cells
  • Targeted therapy – drugs that target changes that are specific to your cancer cells

If you receive systemic therapy and undergo surgery for your early NSCLC, your doctor may use these terms to describe when the systemic therapy is used:

  • Neoadjuvant: Systemic therapy (or radiation) given before surgery.
  • Adjuvant: Systemic therapy (or radiation) given after surgery.

Radiation

Stereotactic ablative radiotherapy (SABR), is a type of radiation that gives a high dose of radiation to the tumor, but little to your healthy tissues. It is a treatment of choice for small tumors when surgery may not be the best treatment.

SBRT is often given in 1 to 5 treatments. Radiation beams are aimed at the tumor from different angles. To help target the radiation to your tumor,  you are put in a body frame for each treatment. This reduces the movement of the lung tumor during breathing and helps make sure the radiation targets your tumor and not your healthy tissues.

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Search

[divi_global_search_form]

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for retinopathy of prematurity (ROP). Click on one of the options below to learn more about ROP.

Patient Toolkit

Patient Toolkit

Read more

What exactly is NSCLC?

What exactly is NSCLC?

Read more

What symptoms can NSCLC cause?

What symptoms can NSCLC cause?

Read more

How is NSCLC treated according to staging?

How is NSCLC treated according to staging?

Read more

How is early NSCLC treated with surgery or SBRT?

How is early NSCLC treated with surgery or SBRT?

Read more

When is chemotherapy used in NSCLC?

When is chemotherapy used in NSCLC?

Read more

When is radiation used in NSCLC?

When is radiation used in NSCLC?

Read more

When is immunotherapy used in NSCLC?

When is immunotherapy used in NSCLC?

Read more

When is targeted therapy used in NSCLC?

When is targeted therapy used in NSCLC?

Read more

Online resources

Online resources

Read more
This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM). This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | ROP Relief | All Rights Reserved | Website by Divigner